tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

GLSI Stock Latest News

Greenwich LifeSciences provides global update on FLAMINGO-01
The FlyGreenwich LifeSciences provides global update on FLAMINGO-01
15d ago
GLSI
Greenwich LifeSciences announces ‘positive’ data from FLAMINGO-01 trial
PremiumThe Fly
Greenwich LifeSciences announces ‘positive’ data from FLAMINGO-01 trial
16d ago
GLSI
Greenwich LifeSciences Delays Yearly Report Filing
PremiumCompany Announcements
Greenwich LifeSciences Delays Yearly Report Filing
18d ago
GLSI
Greenwich LifeSciences provides update on FLAMINGO-01 trial
PremiumThe Fly
Greenwich LifeSciences provides update on FLAMINGO-01 trial
1M ago
GLSI
Greenwich LifeSciences provides update on FLAMINGO-01 open label HLA data
PremiumThe Fly
Greenwich LifeSciences provides update on FLAMINGO-01 open label HLA data
2M ago
GLSI
Greenwich LifeSciences expands FLAMINGO-01 clinical trial into Europe
PremiumThe FlyGreenwich LifeSciences expands FLAMINGO-01 clinical trial into Europe
3M ago
GLSI
Greenwich LifeSciences announces activation of Phase 3 trial in Poland
Premium
The Fly
Greenwich LifeSciences announces activation of Phase 3 trial in Poland
3M ago
GLSI
Greenwich LifeSciences provides update on commercial manufacturing of GP2
Premium
The Fly
Greenwich LifeSciences provides update on commercial manufacturing of GP2
3M ago
GLSI
Greenwich LifeSciences partners with GBG in Germany for breast cancer trial
PremiumThe Fly
Greenwich LifeSciences partners with GBG in Germany for breast cancer trial
3M ago
GLSI
Greenwich LifeSciences partners with Unicancer expanding Flamingo-01 into France
PremiumThe Fly
Greenwich LifeSciences partners with Unicancer expanding Flamingo-01 into France
3M ago
GLSI
Greenwich LifeSciences partners with GIM in Italy for breast cancer trial
PremiumThe Fly
Greenwich LifeSciences partners with GIM in Italy for breast cancer trial
5M ago
GLSI
Greenwich LifeSciences files $275M mixed securities shelf
PremiumThe Fly
Greenwich LifeSciences files $275M mixed securities shelf
6M ago
GLSI
Greenwich LifeSciences price target raised to $38 from $36 at H.C. Wainwright
PremiumThe FlyGreenwich LifeSciences price target raised to $38 from $36 at H.C. Wainwright
8M ago
GLSI
Greenwich LifeSciences provides update on FLAMINGO-01 trial
Premium
The Fly
Greenwich LifeSciences provides update on FLAMINGO-01 trial
9M ago
GLSI
Greenwich LifeSciences set to join Russell 2000 Index
Premium
The Fly
Greenwich LifeSciences set to join Russell 2000 Index
10M ago
GLSI
Fly Insider: Occidental, Applied Materials among week’s notable insider trades
PremiumThe Fly
Fly Insider: Occidental, Applied Materials among week’s notable insider trades
10M ago
AGO
AJG
Greenwich LifeSciences to sell 174,825 shares at $14.30 in private placement
PremiumThe Fly
Greenwich LifeSciences to sell 174,825 shares at $14.30 in private placement
10M ago
GLSI
Greenwich LifeSciences extends lock-up of directors and officers
PremiumThe Fly
Greenwich LifeSciences extends lock-up of directors and officers
1y ago
GLSI
Greenwich LifeSciences initiates first clinical sites in Europe
PremiumThe Fly
Greenwich LifeSciences initiates first clinical sites in Europe
1y ago
GLSI
Greenwich LifeSciences’ Flamingo-01 Phase 3 trial expanding in Europe
PremiumThe FlyGreenwich LifeSciences’ Flamingo-01 Phase 3 trial expanding in Europe
1y ago
GLSI
Greenwich LifeSciences’ Phase 3 trial protocol accepted by European regulators
Premium
The Fly
Greenwich LifeSciences’ Phase 3 trial protocol accepted by European regulators
1y ago
GLSI
Greenwich LifeSciences price target lowered to $36 from $38 at H.C. Wainwright
Premium
The Fly
Greenwich LifeSciences price target lowered to $36 from $38 at H.C. Wainwright
1y ago
GLSI

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >